dendritic cells

BIOLOGICAL7 trials

Sponsors

Radboud University Medical Center, Masonic Cancer Center, University of Minnesota, Clinica Universidad de Navarra, Universidad de Navarra, Hebei Yanda Hospital, Fundación Salud de los Andes

Conditions

Anaplastic AstrocytomaBladder CancerBrain TumorBreast Cancer FemaleCentral Nervous System TumorEpendymomaGlioblastomaGlioma

Phase 1

Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients

CompletedNCT00847106

Radboud University Medical CenterMelanoma

Start: 2004-03-31End: 2005-10-31Target: 15Updated: 2009-02-19

Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor

CompletedNCT01171469

Masonic Cancer Center, University of MinnesotaAnaplastic Astrocytoma, Brain Tumor, Ependymoma +2

Start: 2010-09-30End: 2012-06-30Updated: 2017-12-02

Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults

CompletedNCT02496520

Clinica Universidad de Navarra, Universidad de NavarraCentral Nervous System Tumor, Sarcoma

Start: 2014-09-30End: 2019-05-27Updated: 2020-02-21

Immunogenicity and Safety of DCs in Breast Cancer

CompletedNCT03450044

Fundación Salud de los AndesBreast Cancer Female

Start: 2014-01-31End: 2018-08-31Updated: 2020-02-05

Phase 2

Treatment of Recurrent Bladder Cancer With Dendritic Cells

CompletedNCT04184232

Institute of Biophysics and Cell Engineering of National Academy of Sciences of BelarusBladder Cancer

Start: 2019-07-01End: 2020-12-31Updated: 2021-01-22

Dendritic Cell-immunotherapy for Advanced Hepatocellular Carcinoma

Active, not recruitingNCT07726329

Chang Gung Memorial HospitalLiver Neoplasms

Start: 2019-07-01End: 2028-02-01Target: 100Updated: 2026-07-24

Unknown Phase

Safety and Efficacy of IDH1R132H-DC Vaccine in Gliomas

Hebei Yanda HospitalGlioma

Start: 2016-02-29End: 2019-01-31Target: 30Updated: 2016-05-13

Related Papers

Autologous Dendritic Cells in Combination With Chemotherapy Restore Responsiveness of T Cells in Breast Cancer Patients: A Single-Arm Phase I/II Trial

Frontiers in Immunology2021-08-2035 citations

Emerging targets for anticancer vaccination: IDH.

2021-07-1316 citations